Pharmaceutical Vials Market

Global Pharmaceutical Vials Market Overview

The global pharmaceutical vials market, valued at USD 11.65 billion in 2025, is projected to reach USD 12.33 billion in 2026 and USD 15.85 billion by 2030, with a 6.5% CAGR during the forecast period, 2026 to 2030.

To learn more about this report, request a free sample copy

Over the years, advances in drug / therapy development processes have led the pharmaceutical industry to gradually shift from a one-drug treats all model to a more personalized approach of treatment. The growing complexity of modern pharmacological interventions, such as monoclonal antibodies, and cell and gene therapies, has further prompted the drug developers to develop or identify specialized fill / finish and packaging alternatives that are capable of catering to the specific needs of such novel products.

Pharmaceutical packaging, owing to the fact that it is in immediate contact with the drug / therapy formulation, plays a vital role in preserving the identity, quality and integrity of the packaged medicinal product. Although there are various types of primary packaging containers, including ampoules, cartridges and syringes, available in the market for various types of drug formulations, pharmaceutical vials have been observed to be the preferred choice of drug developers, owing to the fact that they provide high container-closure integrity.

Despite being the most preferred packaging system, traditional vials are often associated with certain challenges, including chances of breakage under extreme conditions, absence of relevant information (serial or batch number) on the package and potential to delaminate. As a result, several pharmaceutical vial manufacturers are exploring novel techniques to overcome the aforementioned challenges associated with conventional pharmaceutical vials in order to create better packaging solutions. Examples of some advancements in this domain include the use of serialization techniques (to avoid drug counterfeiting), development of numerous coating materials (to prevent delamination and pH imbalance) and the adoption of smart drug delivery technologies (to improve patient compliance).

Further, pre-sterilized / ready-to-use (RTU) pharmaceutical vials have emerged as a promising alternative to conventional pharmaceutical vials, adding significant value to streamline pharmaceutical fill / finish operations. It is worth noting that these innovations have significantly helped in optimizing costs, easing the filling process and expediting production timelines. Moreover, it enables the pharmaceutical players to overcome regulatory challenges, as well as build a sustainable competitive edge in the market. In addition, due to the unprecedent outbreak of COVID-19 pandemic, the demand for parenteral formulations has increased significantly, therefore providing lucrative opportunities for pharmaceutical companies engaged in the development of safe and superior quality vials. In the future, the high demand for parenteral formulations and increase in vaccination campaigns are likely to drive the growth of the pharmaceutical vials market. A closely associated opportunity exists in aseptic filling machines, where the direct equipment-to-process relationship links the source market with a complementary product, platform or service.

Key Vial Manufacturers in Pharmaceutical Vials Market

Examples of key vial manufacturers engaged in manufacturing pharmaceutical vials (which have also been profiled in this market report; the complete list of companies is available in the full report) include Corning, DWK Life Sciences, Pacific Vial Manufacturing, Thermo Fischer Scientific, Worldwide Glass Resources, Gerresheimer, Origin Pharma Packaging, SCHOTT, SGD Pharma, Stevanato Group, Chongqing Zhengchuan Pharmaceutical Packaging, DANYANG XIANGHE PHARMACEUTICAL PACKAGING, Ningbo Zhengli Pharmaceutical Packaging, Nipro and Shandong Pharmaceutical Glass. The pharmaceutical vials market report includes an easily searchable excel database of all the vial manufacturers, worldwide.

Recent Developments in Global Pharmaceutical Vial Market:

Several recent developments have taken place in the field of global pharmaceutical vial. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

• In December 2025, Corning launched its Viridian pharmaceutical vials, designed to improve filling-line efficiency and reduce CO2 emissions by using 20% less glass and 100% renewable energy in manufacturing for parenteral drug and vaccine packaging.

Scope of the Report

The “Global Pharmaceutical Vials Market – Industry Trends and Global Forecasts, till 2030” report features an extensive study of the current market landscape and future potential of pharmaceutical vials over the next decade. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:

• A detailed assessment of the current market landscape of pharmaceutical vials, featuring information on the type of fabrication material used for container (glass and plastic), type of fabrication material used for closure (rubber, plastic and metal), volume of vial (less than 50 ml, 50 ml to 100 ml and more than 100 ml), type of vial cap (screw cap, crimp cap and snap cap), sterilization status (pre-sterilized and unsterilized), type of product (untreated and treated), compatible drug class (biologics and small molecules) and type of formulation stored (liquid, powder and solid). In addition, the chapter includes analysis related to pharmaceutical vial manufacturers based on various parameters, including year of establishment, company size, location of headquarters and key players (in terms of number of products).
• A competitiveness analysis of pharmaceutical vial manufacturers, segmented into four categories, namely small (1-50 employees), mid-sized companies (51-500 employees), and large (501-1,000 employees) and very large companies (more than 1,000 employees). Within the peer group, companies were ranked based on various relevant parameters, such as supplier power (based on the experience / expertise of the manufacturer) and key product specifications (type of fabrication material used, type of vial cap, sterilization status, type of product, compatible drug class and type of formulation stored).

• Elaborate profiles of prominent players engaged in the development of pharmaceutical vials, based in North America, Europe and Asia Pacific. Each profile features a brief overview of the company, details related to its financials (if available), product portfolio, recent developments and an informed future outlook.
• An analysis of the partnerships that have been inked by stakeholders engaged in this domain, since 2015 (till September), covering acquisitions, product / technology integration agreements, supply agreements, asset acquisitions, distribution agreements, product / technology development agreements, product / technology licensing agreements, and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of fabrication material involved, sterilization status, type of partners and regional distribution of the collaborations.
• An elaborate discussion on the key trends (such as the advent of personalized / targeted therapies, shift towards more flexible packaging, rise of modular manufacturing facilities and advancement in robotic packaging solutions) that are likely to have an impact on the future adoption of innovative primary packaging systems. It also features a harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
• An in-depth analysis to estimate the current and future demand for pharmaceutical vials based on various relevant parameters, such as type of fabrication material used, sterilization status and regions, for the period, till 2030.
• A case study on the use of robotic machinery in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. Further, it presents the profiles of industry players that provide such equipment for aseptic processing of pharmaceuticals.
• A case study on pre-sterilized / RTU pharmaceutical vials that are available nowadays. In addition, it provides information on the various sterilization techniques used for primary packaging materials and the advantages of RTU container-closure systems.

One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for pharmaceutical vials over the coming decade. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of these products, we have provided an informed estimate on the likely evolution of the market till 2030. The report provides sales forecasts for the overall pharmaceutical vials market, wherein both the current and upcoming opportunity is segmented across [A] type of fabrication material used (glass and plastic), [B] sterilization status (pre-sterilized and unsterilized) and [C] key geographies (North America, Europe, Asia Pacific, Middle East and North Africa, Latin America and Rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

• Business Development and Technology Director, Small Company, Belgium
• Former Project Manager of Business Development, Mid-sized Company, US
• President, Mid-sized Company, US